Deutsche Bank AG Sells 1,448 Shares of Simulations Plus, Inc. $SLP

Deutsche Bank AG decreased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 9.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,468 shares of the technology company’s stock after selling 1,448 shares during the period. Deutsche Bank AG owned approximately 0.07% of Simulations Plus worth $330,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Barclays PLC lifted its holdings in shares of Simulations Plus by 2.7% in the 4th quarter. Barclays PLC now owns 29,229 shares of the technology company’s stock worth $815,000 after acquiring an additional 756 shares during the last quarter. First Trust Advisors LP raised its position in Simulations Plus by 47.3% in the 4th quarter. First Trust Advisors LP now owns 9,393 shares of the technology company’s stock worth $262,000 after purchasing an additional 3,015 shares during the period. Dimensional Fund Advisors LP raised its position in Simulations Plus by 6.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company’s stock worth $11,693,000 after purchasing an additional 24,266 shares during the period. Tower Research Capital LLC TRC lifted its stake in Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock worth $72,000 after purchasing an additional 764 shares during the last quarter. Finally, State of Tennessee Department of Treasury boosted its position in shares of Simulations Plus by 21.0% during the fourth quarter. State of Tennessee Department of Treasury now owns 11,813 shares of the technology company’s stock valued at $329,000 after buying an additional 2,052 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Performance

Shares of SLP opened at $14.22 on Friday. The company has a 50 day moving average price of $14.90 and a 200-day moving average price of $24.25. Simulations Plus, Inc. has a fifty-two week low of $12.39 and a fifty-two week high of $37.67. The stock has a market capitalization of $286.25 million, a PE ratio of -4.51 and a beta of 0.76.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.19. The company had revenue of $20.36 million during the quarter, compared to the consensus estimate of $22.83 million. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. Simulations Plus’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.27 earnings per share. Equities research analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Analyst Upgrades and Downgrades

SLP has been the topic of several recent analyst reports. Zacks Research upgraded Simulations Plus to a “hold” rating in a report on Tuesday, August 12th. JMP Securities reaffirmed a “market perform” rating on shares of Simulations Plus in a research report on Wednesday, June 18th. KeyCorp downgraded Simulations Plus from an “overweight” rating to a “sector weight” rating in a research report on Tuesday, July 15th. Stephens cut their price target on shares of Simulations Plus from $28.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, July 15th. Finally, BTIG Research reduced their price target on shares of Simulations Plus from $41.00 to $25.00 and set a “buy” rating on the stock in a research note on Monday, July 7th. Four investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.